Genmab A/S (OTCMKTS:GNMSF) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

Genmab A/S (OTCMKTS:GNMSFGet Free Report) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $213.37 and traded as high as $225.00. Genmab A/S shares last traded at $222.21, with a volume of 278 shares changing hands.

Genmab A/S Stock Down 0.6 %

The firm has a market cap of $14.43 billion, a price-to-earnings ratio of 21.23 and a beta of 1.04. The company has a 50-day moving average price of $213.34 and a 200 day moving average price of $240.50.

Genmab A/S Company Profile

(Get Free Report)

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.

Recommended Stories

Receive News & Ratings for Genmab A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genmab A/S and related companies with MarketBeat.com's FREE daily email newsletter.